A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission.

Katerina Chatzidionysiou, Carl Turesson, Annika Teleman, Ann Knight, Elisabet Lindqvist, Per Larsson, Lars Cöster, Kristina Forslind, Ronald van Vollenhoven, Mikael Heimbürger

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Fingeravtryck

Fördjupa i forskningsämnen för ”A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission.”. Tillsammans bildar de ett unikt fingeravtryck.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology